Can you do the math based on a more recent quarterly earnings report from Merck?
"Merck's popular antibody treatment Keytruda, which is used to treat several types of cancer, booked $6.34 billion in revenue, up 17% from the year-earlier quarter."CNBC
Great point - they are growing far faster and likely the 5x dramatically understates the difference in spend per recipient. Thanks for following along.
Can you do the math based on a more recent quarterly earnings report from Merck?
"Merck's popular antibody treatment Keytruda, which is used to treat several types of cancer, booked $6.34 billion in revenue, up 17% from the year-earlier quarter."CNBC
Great point - they are growing far faster and likely the 5x dramatically understates the difference in spend per recipient. Thanks for following along.